Web Results
www.livemint.com/science/news/zolgensma-the-world-s-most-expensive-drug-costs-rs-18-crore-per-dose-5-points-11615253464861.html

Mar 9, 2021 ... Zolgensma is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric patient less than 2 years of age ...

www.abc.net.au/news/2019-05-25/worlds-most-expensive-drug-spinal-muscular-dystrophy/11149788

The world's most expensive drug has been approved for treating spinal muscular atrophy (SMA) in infants, with the one-off treatment costing ...

www.npr.org/sections/health-shots/2019/05/24/725404168/at-2-125-million-new-gene-therapy-is-the-most-expensive-drug-ever

May 24, 2019 ... Zolgensma, a new drug approved by the FDA Friday, costs more than $2.1 million. ... The only existing treatment for spinal muscular atrophy, ...

www.aa.com.tr/en/health/sma-treatment-controversy-over-efficacy-price/2099545

Jan 6, 2021 ... Patients must use the drug their entire lives, while a 10-year long therapy with this medicine costs around $10 million. The efficacy of the ...

www.managedhealthcareexecutive.com/view/fda-approves-evrysdi-risdiplam-third-drug-for-spinal-muscular-atrophy

Aug 10, 2020 ... Zolgensma, a one-time gene therapy treatment, is priced at $2.1 ... Evrysdi (risdiplam) will be priced so the highest annual cost will be ...

www.fiercepharma.com/pharma/novartis-ps1-79m-gene-therapy-zolgensma-scores-nice-backing-threatening-biogen-s-spinraza

Mar 8, 2021 ... Cost watchdogs at England's NICE have clashed repeatedly with ... The deal recommends treatment with Zolgensma before SMA symptoms develop.

indianexpress.com/article/india/couple-hopes-to-crowdfund-rs-16-crore-to-treat-2-year-old-sons-genetic-disorder-7194916

Feb 19, 2021 ... The Novartis manufactured Zolgensma gene therapy to treat spinal muscular atrophy (SMA) is the most expensive medicine globally; it costs 2.1 ...

www.swissinfo.ch/eng/explainer_how-can-a-drug-cost--2.1-million-/44996728

May 29, 2019 ... Zolgensma is not the only treatment to raise eyebrows because of its price tag. A couple of years ago, a debate ensued in Switzerland over ...

www.biopharmadive.com/news/gene-therapy-could-be-cost-effective-in-sma-but-not-at-4m/544969

Dec 21, 2018 ... One-time treatment with an experimental gene therapy for spinal muscular atrophy could be more cost effective than Biogen's marketed drug ...

www.cnbc.com/2021/03/08/nhs-approved-a-drug-that-costs-2point5-million.html

Mar 8, 2021 ... The innovative gene therapy, called Zolgensma, has a reported list ... on the cost-effectiveness of drugs and treatments used by the NHS ...

www.statnews.com/2019/05/31/spinal-muscular-atrophy-zolgensma-price-critics

May 31, 2019 ... Long-term value. The first two years of treatment with Spinraza cost around 50% of one Zolgensma infusion, but Spinraza treatments must continue ...